Sosic, A.; Olivato, G.; Carraro, C.; Göttlich, R.; Fabris, D.; Gatto, B. In Vitro Evaluation of Bis-3-Chloropiperidines as RNA Modulators Targeting TAR and TAR-Protein Interaction. Int. J. Mol. Sci.2022, 23, 582.
Sosic, A.; Olivato, G.; Carraro, C.; Göttlich, R.; Fabris, D.; Gatto, B. In Vitro Evaluation of Bis-3-Chloropiperidines as RNA Modulators Targeting TAR and TAR-Protein Interaction. Int. J. Mol. Sci. 2022, 23, 582.
Sosic, A.; Olivato, G.; Carraro, C.; Göttlich, R.; Fabris, D.; Gatto, B. In Vitro Evaluation of Bis-3-Chloropiperidines as RNA Modulators Targeting TAR and TAR-Protein Interaction. Int. J. Mol. Sci.2022, 23, 582.
Sosic, A.; Olivato, G.; Carraro, C.; Göttlich, R.; Fabris, D.; Gatto, B. In Vitro Evaluation of Bis-3-Chloropiperidines as RNA Modulators Targeting TAR and TAR-Protein Interaction. Int. J. Mol. Sci. 2022, 23, 582.
Abstract
After a long limbo, RNA has gained its credibility as a druggable target, fully earning its de-served role in the next-generation area of pharmaceutical R&D. We have recently probed the Trans-Activation Response element (TAR), a RNA stem–bulge–loop domain of the HIV-1 genome with bis-3-chloropiperidines (B-CePs), and revealed the compounds unique behavior in stabiliz-ing TAR structure, thus impairing in vitro the chaperone activity of the HIV-1 nucleocapsid (NC) protein. Seeking to elucidate the determinants of B-CePs inhibition, we have further characterized here their effects on the target TAR and its NC recognition, while developing quantitative analyti-cal approaches for the study of multicomponent RNA-based interactions.
Chemistry and Materials Science, Medicinal Chemistry
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
